Global 500
AbbVieRANK247
AbbVie started 2021 strong, surpassing first-quarter earnings and revenue estimates. The Chicago-based pharmaceutical company saw a revenue increase in the first quarter from its primary breadwinner, Humira, in the U.S. The drug has faced steep competition globally from biosimilars, but AbbVie made up for it with increased sales from recently released plaque psoriasis drug Skyrizi and treatment for severe rheumatoid arthritis, Rinvoq. The two drugs made $2.3 billion just 12 months after being released. In 2019 AbbVie acquired Allergan for an eye-popping $63 billion and is now starting to reap the benefits. Allergan’s products, which includes Botox, made up almost 20% of AbbVie’s 2020 revenue.
Courtesy of AbbVie
Lists ranking AbbVie
RANK99
100 Best Large Workplaces for Millennials - 2021We surveyed tens of thousands of employees to crea...view in list
RANK58
100 Best Companies to Work For - 2021Our 2021 list of the 100 best companies to work fo...view in list
RANK3
20 Best Workplaces in Biotechnology and Pharmaceuticals - 2021The best U.S. biotechnology and pharmaceutical com...view in list
World’s Most Admired Companies - 2021After a year in which humanity leaned more heavily...view in list
Latest news for AbbVie
- MagazineBig Hospitals vs. Big Pharma: Which industry is most to blame for soaring health care costs?April 8, 2021 10:30 AM UTC
- HealthIt’s the New Year, and pharma companies are already hiking prices for popular drugsJanuary 4, 2021 8:35 PM UTC
- MPWThree more women have died from cancer linked to Allergan’s recalled breast implants, FDA saysAugust 24, 2020 4:48 PM UTC